AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06444568 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: The intervention includes the application and follow-up of different diet therapies to individuals (Ketogenic diet and MIND).
Study NCT05014971 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-neurohub
Description: Interdisciplinary care delivered using telemedicine (zoom) technology which includes neurologist, physical, occupational and speech therapy, social worker and dietician.
Study NCT05014971 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tele-neurohub
Description: Interdisciplinary care delivered using telemedicine (zoom) technology which includes neurologist, physical, occupational and speech therapy, social worker and dietician.
Study NCT05444569 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC.
Study NCT06234189 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Defocus Incorporated Multiple Segment Spectacle Lenses (DIMS)
Description: 30 minutes without DIMS and 30 minutes with DIMS
Study NCT05259566 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: menthol ban in cigarettes only
Description: menthol ban in cigarettes only, menthol available in e-cigarette
Study NCT05259566 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: total menthol ban
Description: menthol ban in both cigarettes and e-cigarettes
Study NCT05415761 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: iCanQuit
Description: iCanQuit is a smoking cessation smart phone application that uses acceptance and commitment therapy (ACT) approach, a cognitive behavioral treatment
Study NCT05415761 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: iCanQuit+Motiv8
Description: iCanQuit + Motiv8 is a integrated version of iCanQuit (Cognitive Behavioral Therapy smoking cessation therapy application) with Motiv8 (a contingency management program that rewards decreased smoking determined by measuring CO levels of participant)
Study NCT05415761 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Florida quit line
Description: An evidence-based, existing smoking cessation healthcare option recommended by the U.S. clinical practice that connects active smokers to trained quit coaches via referral by their providers.
Study NCT06485479 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention ads
Description: The ads will be on topics to encourage quitting smoking, formatted as multi-color text with graphic elements. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Study NCT06485479 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control ads
Description: The ads will be on topics unrelated to quitting smoking, formatted as black text on a white field. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Study NCT05478265 — intervention group
Intervention type: DEVICE
Intervention: RS-4i Plus
Description: RS-4i Plus in an FDA-regulated prescription TENS medical device that outputs and INF signal and a NMES signal and Intersperse signal, which combines INF and NMES into a single treatment.
Study NCT05995210 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: A corrective kinesio taping was applied to the patellofemoral joint for the knee. In addition, exercise therapy was taken.
Study NCT05995210 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthosis
Description: They were asked to use a knee orthosis for a minimum of 6 hours a day. They also received exercise therapy.
Study NCT05995210 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: An exercise program focused on the knee and hip muscles was given two days a week.
Study NCT05995210 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Control
Description: An exercise program focused on the knee and hip muscles was given two days a week.
Study NCT05379803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: furmonertinib 160 mg orally QD
Study NCT05701423 — intervention group
Intervention type: DRUG
Intervention: Natalizumab
Description: Administered as specified in the treatment arm.
Study NCT06033222 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ricinoleic Acid 750 mg
Description: 750 mg administered orally
Study NCT06033222 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ricinoleic Acid 1500 mg
Description: 1500 mg administered orally
Study NCT06033222 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ricinoleic Acid 3000 mg
Description: 3000 mg administered orally
Study NCT06033222 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Contains no active ingredient.
Study NCT06305650 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Probiotic
Description: Through oral probiotic intervention for 12 weeks, participants' BMI, body fat percentage, and waist-to-hip ratio will be measured at weeks 0, 6, and 12, and fecal samples will be collected at weeks 0 and 12 for gut microbiota analysis.
Study NCT06305650 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Through oral probiotic intervention for 12 weeks, participants' BMI, body fat percentage, and waist-to-hip ratio will be measured at weeks 0, 6, and 12, and fecal samples will be collected at weeks 0 and 12 for gut microbiota analysis.
Study NCT05142787 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Magseed Pro(R) and Sentimag(R) Gen3 by Endomagnetics
Description: placement of Magseed Pro \& localisation with Sentimag Gen3 in axillary lymph nodes and/or breast lesions
Study NCT05460754 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional-fed beef
Description: Participants in the conventional-fed treatment of the study will consume a conventional-fed steak meal for breakfast one morning.
Study NCT05460754 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Organic grass-fed beef
Description: Participants in the organic grass-fed treatment of the study will consume a organic grass-fed steak meal for breakfast one morning.
Study NCT06275685 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SeizureWise algorithm
Description: An investigational algorithm which enables forecasting of future seizure probabilities based on the pattern and frequency of previous generalized tonic-clonic seizure (GTCS) events, as well as changes in physiological and behavioral variables
Study NCT06275685 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Multi-day Visualizations
Description: Multi-day visualizations of sensor derived data
Study NCT06275685 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multi-day Visualizations
Description: Multi-day visualizations of sensor derived data
Study NCT05093270 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGB-23339
Description: Administered orally as a tablet
Study NCT05093270 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered orally as a tablet
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TBAJ-876
Description: tablet
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pretomanid
Description: 200 mg
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pretomanid
Description: 200 mg
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linezolid
Description: 600 mg
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid
Description: 600 mg
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bedaquiline
Description: 200 mg for 8 weeks followed by 100 mg for 18 weeks
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HRZE
Description: Isoniazid (H) + rifampicin (R) + pyrazinamide (Z) plus ethambutol (E) fixed dose combination tablets dosed by weight
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HR
Description: Isoniazid (H) + rifampicin (R) fixed dose combination tablets dosed by weight
Study NCT06058299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR
Description: Isoniazid (H) + rifampicin (R) fixed dose combination tablets dosed by weight
Study NCT04720183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Description: On Day 1, Day 5 and Day 9, a single oral dose of sulfasalazine tablets in fasted state.
Study NCT04720183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLPG3970
Description: On Day 5 and Day 9, a single dose of GLPG3970 oral solution in fasted state.
Study NCT06466746 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Raising the Pulse faba bean-enriched bread
Description: 100 g of white bread produced using 40% faba bean enriched flour and 60% wheat flour will be provided in the breakfast meal with stork margarine, chocolate spread, a glass of orange juice and a glass of water containing the iron-57 stable isotope. An ad-libitum lunch consisting of pasta and a tomato sauce will be provide 6 hours after the breakfast.
Study NCT06466746 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional White Bread
Description: 100 g of white bread produced using 100% wheat flour will be provided in the breakfast meal with stork margarine, chocolate spread, a glass of orange juice and a glass of water containing the iron-57 stable isotope. An ad-libitum lunch consisting of pasta and a tomato sauce will be provide 6 hours after the breakfast.
Study NCT05148156 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Urolift
Description: Study intervention involves a one-time administration of Urolift in out-patient setting prior to Stereotactic body radiation therapy (SBRT).
Study NCT06071377 — intervention group
Intervention type: OTHER
Intervention: Biologic Specimen Collection
Description: Participants will have blood and urine collected annually at Baseline, Year 1 and Year 2.
Study NCT05321134 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single port robotic colorectal surgical procedure
Description: After screening and counseling, study subjects who wish to participate will undergo the colorectal surgical procedure (determined based on routine standard clinical care) using the alternate Intuitive Da Vinci Single Port SP system rather than the currently used multiport system, (Intuitive Da Vinci Multiport Xi System).~Using standardized case report forms, the investigators will track clinical parameters and describe the safety \& quality event rate for SP platform transabdominal and transanal colorectal operations.
Study NCT06091241 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Pre-operative Erector Spinae Plane block prior to DIEP surgery
Description: After obtaining informed consent to participate in the study, patients will be randomized by a computer 50/50 to either the Erector Spinae Plane group or the Transversus Abdominus Plane group at the time of their surgical clinic visit prior to their scheduled surgery. Then on the morning of surgery, the Erector Spinae Plane group will receive a bilateral ultrasound-guided Erector Spinae Plane peripheral nerve block. During this intervention, 0.25% bupivacaine with dexamethasone will be injected below the fascia of the erector spinae muscle group.
Study NCT06091241 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Pre-operative Transversus Abdominus Plane blocks prior to DIEP surgery
Description: On the morning of surgery, the patients in the TAPs group will receive a bilateral ultrasound-guided Transversus Abdominus plane peripheral nerve block. During this intervention, 0.25% bupivacaine with dexamethasone will be injected into the transversus abdominus plane above the transversus abdominus muscle.
Study NCT06195748 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: According to the manufacturer, the controllable variables in KT application included degree of pre-stretch applied to the tape (75-100%), the location and treatment goals. The subject will be asked to lie supine, with the ankle of the dominant side in neutral position. A Y shaped KT strip will be applied from the heel to lateral and medial femoral condyles. A I shaped KT strip will be applied from medial malleolus to lateral malleolus, passing under the heel. Another I shaped KT strip will be applied from slightly above the medial malleolus to slightly above the lateral malleolus, crossing on the instep at the malleoli level.
Study NCT06195748 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo kinesiotaping
Description: The same tape will be used for the interventional application with 0 tension.
Study NCT06565429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5-Step Method Intervention
Description: The 5-Step Method (5SM) intervention is delivered through a self-help handbook: There are writing prompts for the affected family member (AFM) in each step. The steps end with a summary, a space to reflect and a statement that the step is complete but can be reviewed as needed. The steps are: 1.Explore how the relative's drug and/or alcohol misuse is affecting the family member, causing stress and strain. 2.Determine the information the AFM needs to understand the situation using evidence-based websites in the handbook. 3.Reflect on coping styles, and which ones might be useful. 4.Determine who is a source of positive social support, and who could be one that the AFM has not used yet. 5.Review steps 1-4 and determine if the AFM is feeling less stress and strain, or if more help is needed and use websites to look for additional help. The activities should take about 1 hour per week.
Study NCT05876754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivosidenib Oral Tablet
Description: Ivosidenib 500 mg
Study NCT05417438 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wearable device deployment
Description: Participants will receive a Fitbit to be synced with a smartphone app (MyDataHelps). Participants will receive push notifications to complete surveys via the MyDataHelps app. The Fitbit will sync with the app for data collection.
Study NCT06601413 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: M-TAPA Block
Description: M-TAPA block will administer ultrasound guided (Sonosite, Inc., Bothell, WA, USA) bilaterally by same anesthesiologist (E.E.) who had more than 10 years experience of regional anesthesia, before weaking from general anesthesia after the surgical procedure. A high-frequency (6-13 MHz) linear probe (HFL38) will be used to identify the transversus abdominis, internal oblique, and external oblique muscles on the costochondral angle in the sagittal plane at the 10th costal margin. In the midclavicular line, between the upper fascia of the transversus abdominis muscle and the lower fascia of the costochondral tissue, at the level of the 10th rib, 20 mL of 0.25 percent bupivacaine will be injected (arcus costarum). The same procedure will be followed on the other side.
Study NCT06601413 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Trocar site local anesthetic infiltration
Description: At the end of surgery, infiltration analgesia will be applied to all trocar entry sites (4 port entries) by the surgeon with 10 ml of 0.25% bupivacaine (40 mL in total) without waking the patient.
Study NCT06595979 — intervention group
Intervention type: DRUG
Intervention: Polymyxin B
Description: Participants in this group will receive polymyxin B administered directly into the brain (intracranial administration) without intravenous (IV) infusion.
Study NCT06592729 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: education
Description: intervention group was taken to scenario-based simulat
Study NCT06590974 — intervention group
Intervention type: DRUG
Intervention: Freeze-dried Human Protein C Concentrate
Description: Freeze-dried Human Protein C Concentrate (TAK-662) intravenous injection
Study NCT06593158 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parent-delivered Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) for CP children at camp with the guidance and supervision of experts.
Description: * The caregivers delivering HABIT-ILE therapy at camp will follow the same principles as the usual HABIT-ILE. The therapy will take place in a rehabilitation center, and caregivers will provide therapy during the sessions, coached by trained supervisors on site~* The intervention day will then take place, lasting for 5 hours with the constant presence of supervisors. This will be divided into two sessions: a 3-hour intervention in the morning followed by a lunch break, and a 2-hour intervention in the afternoon.
Study NCT06593158 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parent-delivered Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) for CP children at home with the online guidance and supervision of experts.
Description: * The caregivers delivering HABIT-ILE therapy at home will follow the same principles as the usual HABIT-ILE. The therapy will take place at children's home, caregivers will provide therapy during the sessions, coached by trained supervisors online~* The intervention day will then take place, lasting for 5 hours with the supervisors through online setting. This will be divided into two sessions: a 3-hour intervention in the morning followed by a lunch break, and a 2-hour intervention in the afternoon.
Study NCT06598098 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Modes
Description: Moderate intensity aerobic exercise, moderate intensity resistance exercise, moderate intensity combination exercise
Study NCT06595654 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: repetitive Transcranial Magnetic Stimulation
Description: * Patient is in a chair.~* Hearing protection will be implemented.~* The corresponding targeting method will be implemented.~* The stimulation coil will be set up according to the indications of the targeting method.~* A caregiver is present throughout the session.~* After the session, the patient is re-assessed clinically for possible adverse effects.~* If an adverse reaction is objectified, a doctor on site, is quickly mobilized.
Study NCT06603194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bovine or Marine Collagen
Description: Bovine or Marine Collagen
Study NCT06603194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Bovine or Marine Collagen
Description: Bovine or Marine Collagen
Study NCT06598735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-4508
Description: HRS-4508
Study NCT06594224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Patients were given 800 mg Ibuprofen in 200 cc normal saline intravenously at the time of arrival in the ward.
Study NCT06594224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Description: Patients received 20 mg nalbuphine in 200 cc normal saline IV at the time of arrival in the ward.
Study NCT06602323 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: TMLI/Flu/Mel
Description: Targeted total bone marrow and lymphoid irradiation (TMLI) conformal therapy administered in combination with a reduced-intensity regimen based on Fludarabine and Melphalan.
Study NCT06596083 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplement
Description: oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water
Study NCT06596083 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone ester supplement
Description: Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink
Study NCT06663670 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intraneural Facilitation Therapy
Description: * The initial hold, known as the facilitation hold, involves placing the contralateral joint in a maximal loose-pack position that will be comfortable for the patient. An illustration of this would be positioning the ankle joint on the contralateral side in full plantar flexion and inversion. Throughout the entire session, this position will be maintained using a stretch strap. It is crucial to emphasize that there is no muscle engagement in the joint where the facilitation takes place, only a slight stretch.~* Once the pressure elevation occurs, the subsequent phase known as the secondary hold will be initiated to direct the augmented flow of epineurial blood toward the transperineurial vessels connecting the epiperineum and the endoneurial capillaries of the target area.~* The final maneuver, the sub hold, leverages Bernoulli's principle to augment blood flow through the ischemic endoneurial capillaries experiencing heightened transmural pressure.
Study NCT06663670 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nerve Flossing Technique
Description: Tibial Nerve:~1. Passively flex the hip while dorsiflexing and everting the ankle to create tension; flex the knee to unload, then extend and plantarflex to reload.~2. Flex the hip, extend the knee, and dorsiflex and evert the ankle to induce tension; flex the hip to unload, then extend and plantarflex to reload.~3. Lift the leg, flex the hip, and extend the knee; dorsiflex and evert the ankle to induce tension, then plantarflex to unload.~Common Peroneal Nerve:~1. Passively flex the hip and plantarflex and invert the ankle to induce tension; flex the knee to unload, then extend and dorsiflex to reload.~2. Flex the hip, extend the knee, and plantarflex and invert the ankle to induce tension; flex the hip to unload, then extend and dorsiflex to reload.~3. Lift the leg, flex the hip, and extend the knee; plantarflex and invert the ankle to induce tension, then dorsiflex to unload.